{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:19:10Z","timestamp":1778818750270,"version":"3.51.4"},"reference-count":23,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["US Cardiol"],"abstract":"<jats:p>Cardiogenic shock (CS) is a severe and life-threatening condition caused by the heart\u2019s inability to provide adequate blood flow, leading to systemic hypoperfusion and multiorgan dysfunction. While acute MI and heart failure with reduced ejection fraction are common causes of CS, restrictive cardiomyopathy (RCM) presents a unique challenge due to its underlying hemodynamic complexities related to myocardial stiffness. RCM is characterized by preserved systolic function but impaired ventricular filling, resulting in elevated diastolic pressures and a tendency for rapid decompensation into shock. This review explores the pathophysiology, diagnostic evaluation, and management of CS in RCM. Diagnostic tools such as echocardiography and hemodynamic monitoring are critical for differentiating the causes of CS. Treatment strategies focus on optimizing volume status, arrhythmia control, and, in some cases, mechanical circulatory support. Heart transplantation remains the definitive treatment for eligible patients. Early recognition and tailored interventions are essential for the enhancement of survival and quality of life in these critically ill patients.<\/jats:p>","DOI":"10.15420\/usc.2024.51","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:26:23Z","timestamp":1753881983000},"source":"Crossref","is-referenced-by-count":2,"title":["Cardiogenic Shock in Restrictive Cardiomyopathies: What We Know So Far"],"prefix":"10.15420","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2618-4285","authenticated-orcid":false,"given":"Ossama K","family":"Abou Hassan","sequence":"first","affiliation":[{"name":"Department of Heart Failure and Transplant, Division of Cardiology, Baylor Scott and White Medical Center, Temple, TX, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebere","family":"Chukwu","sequence":"additional","affiliation":[{"name":"Department of Heart Failure and Transplant, Division of Cardiology, Baylor Scott and White Medical Center, Temple, TX, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Schmittner","sequence":"additional","affiliation":[{"name":"Department of Heart Failure and Transplant, Division of Cardiology, Baylor Scott and White Medical Center, Temple, TX, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yevgeny","family":"Khariton","sequence":"additional","affiliation":[{"name":"Department of Heart Failure and Transplant, Division of Cardiology, Baylor Scott and White Medical Center, Temple, TX, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison P","family":"Bahe","sequence":"additional","affiliation":[{"name":"Department of Heart Failure and Transplant, Division of Cardiology, Baylor Scott and White Medical Center, Temple, TX, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michala E","family":"Peltak","sequence":"additional","affiliation":[{"name":"Department of Heart Failure and Transplant, Division of Cardiology, Baylor Scott and White Medical Center, Temple, TX, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cari","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Heart Failure and Transplant, Division of Cardiology, Baylor Scott and White Medical Center, Temple, TX, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lazaros","family":"Nikolaidis","sequence":"additional","affiliation":[{"name":"Department of Heart Failure and Transplant, Division of Cardiology, Baylor Scott and White Medical Center, Temple, TX, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elan","family":"Kuriakose","sequence":"additional","affiliation":[{"name":"Department of Heart Failure and Transplant, Division of Cardiology, Baylor Scott and White Medical Center, Temple, TX, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3198-8771","authenticated-orcid":false,"given":"Detlef","family":"Wencker","sequence":"additional","affiliation":[{"name":"Department of Heart Failure and Transplant, Division of Cardiology, Baylor Scott and White Medical Center, Temple, TX, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Hernandez-Montfort","sequence":"additional","affiliation":[{"name":"Department of Heart Failure and Transplant, Division of Cardiology, Baylor Scott and White Medical Center, Temple, TX, US"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6096","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Mehta A, Vavilin I, Nguyen AH, et al. Contemporary approach to cardiogenic shock care: a state-of-the-art review. Front Cardiovasc Med 2024;11:1354158. https:\/\/doi.org\/10.3389\/fcvm.2024.1354158; PMID:\u00a038545346.","DOI":"10.3389\/fcvm.2024.1354158"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Bohula EA, Katz JN, van Diepen S, et al. Demographics, care patterns, and outcomes of patients admitted to cardiac intensive care units: the critical care cardiology trials network prospective North American multicenter registry of cardiac critical illness. JAMA Cardiol 2019;4:928\u201335. https:\/\/doi.org\/10.1001\/jamacardio.2019.2467; PMID:\u00a031339509.","DOI":"10.1001\/jamacardio.2019.2467"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Tehrani BN, Truesdell AG, Sherwood MW, et al. Standardized team-based care for cardiogenic shock. J Am Coll Cardiol 2019;73:1659\u201369. https:\/\/doi.org\/10.1016\/j.jacc.2018.12.084; PMID:\u00a030947919.","DOI":"10.1016\/j.jacc.2018.12.084"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Hernandez-Montfort J, Kanwar M, Sinha SS, et al. Clinical presentation and in-hospital trajectory of heart failure and cardiogenic shock. JACC Heart Fail 2023;11:176\u201387. https:\/\/doi.org\/10.1016\/j.jchf.2022.10.002; PMID:\u00a036342421.","DOI":"10.1016\/j.jchf.2022.10.002"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Dean LS, Kern MJ. Restriction vs constriction. J Soc Cardiovasc Angiogr Interv 2023;2:100965. https:\/\/doi.org\/10.1016\/j.jscai.2023.100965; PMID:\u00a039132398.","DOI":"10.1016\/j.jscai.2023.100965"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Geske JB, Anavekar NS, Nishimura RA, et al. Differentiation of constriction and restriction: complex cardiovascular hemodynamics. J Am Coll Cardiol 2016;68:2329\u201347. https:\/\/doi.org\/10.1016\/j.jacc.2016.08.050; PMID:\u00a027884252.","DOI":"10.1016\/j.jacc.2016.08.050"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Seferovi\u0107 PM, Polovina M, Bauersachs J, et al. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019;21:553\u201376. https:\/\/doi.org\/10.1002\/ejhf.1461; PMID:\u00a030989768.","DOI":"10.1002\/ejhf.1500"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Narang N, Blumer V, Jumean MF, et al. Management of heart failure-related cardiogenic shock: practical guidance for clinicians. JACC Heart Fail 2023;11:845\u201351. https:\/\/doi.org\/10.1016\/j.jchf.2023.04.010; PMID:\u00a037204365.","DOI":"10.1016\/j.jchf.2023.04.010"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Longinow J, Martens P, Il\u2019giovine ZJ, et al. Hemodynamic response after intra-aortic balloon counter-pulsation in cardiac amyloidosis and cardiogenic shock. J Card Fail 2024;30:1255\u201364. https:\/\/doi.org\/10.1016\/j.cardfail.2024.07.019; PMID:\u00a039389735.","DOI":"10.1016\/j.cardfail.2024.07.019"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Heidenreich PA, Hancock SL, Vagelos RH, et al. Diastolic dysfunction after mediastinal irradiation. Am Heart J 2005;150:977\u201382. https:\/\/doi.org\/10.1016\/j.ahj.2004.12.026; PMID:\u00a016290974.","DOI":"10.1016\/j.ahj.2004.12.026"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Khariton Y, Hassan OA, Hernandez-Montfort JA. Update on cardiogenic shock: from detection to team management. Curr Opin Cardiol 2023;38:108\u201315. https:\/\/doi.org\/10.1097\/HCO.0000000000001017; PMID:\u00a036718620.","DOI":"10.1097\/hco.0000000000001017"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Gupta A, Singh Gulati G, Seth S, Sharma S. Cardiac MRI in restrictive cardiomyopathy. Clin Radiol 2012;67:95\u2013105. https:\/\/doi.org\/10.1016\/j.crad.2011.05.020; PMID:\u00a021975052.","DOI":"10.1016\/j.crad.2011.05.020"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Pereira NL, Grogan M, Dec GW. Spectrum of restrictive and infiltrative cardiomyopathies: Part 1 of a 2-Part Series. J Am Coll Cardiol 2018;71:1130\u201348. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.016; PMID:\u00a029519355.","DOI":"10.1016\/j.jacc.2018.01.016"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Loyaga-Rendon RY, Fermin D, Jani M, et al. Changes in heart transplant waitlist and posttransplant outcomes in patients with restrictive and hypertrophic cardiomyopathy with the new heart transplant allocation system. Am J Transplant 2021;21:1255\u201362. https:\/\/doi.org\/10.1111\/ajt.16325; PMID:\u00a032978873.","DOI":"10.1111\/ajt.16325"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Sridharan L, Wayda B, Truby LK, et al. Mechanical circulatory support device utilization and heart transplant waitlist outcomes in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail 2018;11:e004665. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004665; PMID:\u00a029664407.","DOI":"10.1161\/circheartfailure.117.004665"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Stretch R, Sauer CM, Yuh DD, Bonde P. National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol 2014;64:1407\u201315. https:\/\/doi.org\/10.1016\/j.jacc.2014.07.958; PMID:\u00a025277608.","DOI":"10.1016\/j.jacc.2014.07.958"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Patel SR, Saeed O, Naftel D, et al. Outcomes of restrictive and hypertrophic cardiomyopathies after LVAD: an INTERMACS analysis. J Card Fail 2017;23:859\u201367. https:\/\/doi.org\/10.1016\/j.cardfail.2017.09.011; PMID:\u00a028970073.","DOI":"10.1016\/j.cardfail.2017.09.011"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Kittleson MM, Cole RM, Patel J, et al. Mechanical circulatory support for cardiac amyloidosis. Clin Transplant 2019;33:e13663. https:\/\/doi.org\/10.1111\/ctr.13663; PMID:\u00a031309629.","DOI":"10.1111\/ctr.13663"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Kar B, Gregoric ID, Basra SS, et al. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol 2011;57:688\u201396. https:\/\/doi.org\/10.1016\/j.jacc.2010.08.613; PMID:\u00a020950980.","DOI":"10.1016\/j.jacc.2010.08.613"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Kawabori M, Nordan T, Kapur NK, Couper GS. Protect right: right ventricular failure prevention strategy for left ventricular assist device implantation. Eur J Cardiothorac Surg 2021;59:1128\u201330. https:\/\/doi.org\/10.1093\/ejcts\/ezaa400; PMID:\u00a033236106.","DOI":"10.1093\/ejcts\/ezaa400"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Burkhoff D, Cohen H, Brunckhorst C, et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006;152:469.e1\u20138. https:\/\/doi.org\/10.1016\/j.ahj.2006.05.031; PMID:\u00a016923414.","DOI":"10.1016\/j.ahj.2006.05.031"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Zu\u00f1iga Cisneros J, Stehlik J, Selzman CH, et al. Outcomes in patients with hypertrophic cardiomyopathy awaiting heart transplantation. Circ Heart Fail 2018;11:e004378. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004378; PMID:\u00a029664404.","DOI":"10.1161\/circheartfailure.117.004378"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Miklin DJ, DePasquale EC. Heart transplant outcomes in restrictive cardiomyopathy: UNOS registry analysis of the last three decades. JHLT Open 2024;3:100031. https:\/\/doi.org\/10.1016\/J.JHLTO.2023.100031; PMID:\u00a040145113.","DOI":"10.1016\/j.jhlto.2023.100031"}],"container-title":["US Cardiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.uscjournal.com\/articleindex\/usc.2024.51","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:26:28Z","timestamp":1753881988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.uscjournal.com\/articleindex\/usc.2024.51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":23,"URL":"https:\/\/doi.org\/10.15420\/usc.2024.51","relation":{},"ISSN":["1758-390X","1758-3896"],"issn-type":[{"value":"1758-390X","type":"electronic"},{"value":"1758-3896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"article-number":"e15"}}